Altitude Crest Partners Inc. has disclosed 30 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2024-03-31. The current portfolio value is calculated to be $234.00 Mil. The turnover rate is 57%.
In Altitude Crest Partners Inc.'s current portfolio as of 2024-03-31, the top 5 holdings are
Legend Biotech Corp (LEGN), Danaher Corp (DHR), BridgeBio Pharma Inc (BBIO), Stevanato Group SPA (STVN), Apellis Pharmaceuticals Inc (APLS), not including call and put options.
Altitude Crest Partners Inc. did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Altitude Crest Partners Inc., as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Altitude Crest Partners Inc., which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Altitude Crest Partners Inc..